Heron Therapeutics to announce Q1 2026 financial results on May 11, 2026

Heron Therapeutics, a commercial-stage biotech company, will report its first quarter 2026 financial results on May 11, 2026, with a conference call and webcast scheduled for 8:30 a.m. ET. The company focuses on developing and commercializing innovative therapies for acute care and oncology patients. Investors and interested parties can access the call via phone or webcast on Heron's website, with an archive available for 60 days. This update follows Heron's strong 2025 performance, including significant revenue growth driven by key products.